SJ
Shil Jitendra Shah
About Shil Jitendra Shah
Data last updated:
Shil Jitendra Shah is a Director at Umavida Pharma Private Limited (since 2019) and Director at Nibin Pharmaceuticals Private Limited (since 2010). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹24.56 Cr; the largest is Umavida Pharma Private Limited at ₹24.50 Cr (FY 2025). Earlier, Shil Jitendra Shah was a Director at Lakemedel Pharmaceuticals Private Limited (2014–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2019 | 2019 | ₹24.50 Cr (FY 2025) | Active | |
| Director | 05 Feb 2010 | 2010 | ₹5.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Oct 2014 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shil Jitendra Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bindiya Rakesh Gohel | 09691397 | Umavida Pharma Private Limited | Director |
| Fenil Jitendrakumar Shah | 02990417 | Umavida Pharma Private Limited , Nibin Pharmaceuticals Private Limited | Director |
| Jagdishbhai Bhagwatbhai Desai | 02574236 | Umavida Pharma Private Limited | Director |
| Varun Hasmukh Patel | 00354030 | Umavida Pharma Private Limited | Director |
| Vipul Raghunath Chaudhari | 06877056 | Umavida Pharma Private Limited | Director |
| Jitendra Dasharathlal Shah | 02881775 | Nibin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shil Jitendra Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shil Jitendra Shah
Shil Jitendra Shah currently holds 2 directorships: Umavida Pharma Private Limited (Director, since 20 Mar 2019, revenue ₹24.50 Cr (FY 2025)); Nibin Pharmaceuticals Private Limited (Director, since 05 Feb 2010, revenue ₹5.4 Lakh (FY 2025)).
Shil Jitendra Shah was first appointed on 05 Feb 2010 as Director at Nibin Pharmaceuticals Private Limited. The most recent appointment on record is 20 Mar 2019 at Umavida Pharma Private Limited.
The 2 current companies of Shil Jitendra Shah that report revenue have a combined latest revenue of ₹24.56 Cr: Umavida Pharma Private Limited ₹24.50 Cr (FY 2025); Nibin Pharmaceuticals Private Limited ₹5.4 Lakh (FY 2025).
Shil Jitendra Shah held 1 earlier board appointment: Lakemedel Pharmaceuticals Private Limited (Director, 17 Oct 2014 to 27 Jul 2023).
The current boards of Shil Jitendra Shah's companies include Bindiya Rakesh Gohel (Umavida Pharma Private Limited), Fenil Jitendrakumar Shah (Umavida Pharma Private Limited), Jagdishbhai Bhagwatbhai Desai (Umavida Pharma Private Limited), Varun Hasmukh Patel (Umavida Pharma Private Limited), Vipul Raghunath Chaudhari (Umavida Pharma Private Limited), Jitendra Dasharathlal Shah (Nibin Pharmaceuticals Private Limited).